The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 11045 results:
Author Title [ Type(Desc)] Year
Journal Article
Papadopoulos, P., Viennas E., Gkantouna V., Pavlidis C., Bartsakoulia M., Ioannou Z-M., et al. (2014).  Developments in FINDbase worldwide database for clinically relevant genomic variation allele frequencies.. Nucleic Acids Res. 42(Database issue), D1020-6.
Zarogiannis, S., Deligiorgi T., Stefanidis I., Liakopoulos V., Gourgoulianis K., Molyvdas P. Adam, et al. (2009).  Dexamethasone decreases the transmesothelial electrical resistance of the parietal and visceral pleura.. J Physiol Sci. 59(4), 335-9.
Empeslidis, T., Banerjee S., Vardarinos A., & Konstas A. G. P. (2013).  Dexamethasone intravitreal implant for idiopathic retinal vasculitis, aneurysms, and neuroretinitis.. Eur J Ophthalmol. 23(5), 757-60.
Toulis, K. A., Goulis D. G., Msaouel P., & Koutsilieris M. (2012).  Dexamethasone plus somatostatin-analog manipulation as bone metastasis microenvironment-targeting therapy for the treatment of castration-resistant prostate cancer: a meta-analysis of uncontrolled studies.. Anticancer Res. 32(8), 3283-9.
Kastritis, E., Gavriatopoulou M., Kyrtsonis M-C., Roussou M., Hadjiharissi E., Symeonidis A., et al. (2015).  Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: final analysis of a phase 2 study.. Blood. 126(11), 1392-4.
Tsaousi, GG., & Bilotta F. (2016).  Is dexmedetomidine a favorable agent for cerebral hemodynamics?. Indian Journal of Critical Care Medicine. 20(1), 1.
Tsaousi, G. G., & Bilotta F. (2016).  Is dexmedetomidine a favorable agent for cerebral hemodynamics?. Indian J Crit Care Med. 20(1), 1-2.
Tsaousi, G. G., Pourzitaki C., Aloisio S., & Bilotta F. (2018).  Dexmedetomidine as a sedative and analgesic adjuvant in spine surgery: a systematic review and meta-analysis of randomized controlled trials.. Eur J Clin Pharmacol.
Dardalas, I., Stamoula E., Rigopoulos P., Malliou F., Tsaousi G., Aidoni Z., et al. (2019).  Dexmedetomidine effects in different experimental sepsis in vivo models.. Eur J Pharmacol. 856, 172401.
Kolibianakis, E. M., Venetis C. A., & Tarlatzis B. C. (2011).  DHEA administration in poor responders.. Hum Reprod. 26(3), 730-1; author reply 731.
Galli-Tsinopoulou, A., Grammatikopoulou M. G., Stylianou C., Emmanouilidou E., & Kokka P. (2010).  Diabese youngsters have 3.7 more chances in developing metabolic syndrome compared with the obese.. J Endocrinol Invest. 33(8), 549-53.
Giouleme, O., Diamantidis M. D., & Katsaros M. G. (2011).  Is diabetes a causal agent for colorectal cancer? Pathophysiological and molecular mechanisms.. World J Gastroenterol. 17(4), 444-8.
Paschou, S. A., Anagnostis P., Vryonidou A., & Goulis D. G. (2018).  Diabetes and Atherosclerosis: Old Players in a New Field, Osteoporosis.. Curr Vasc Pharmacol. 16(6), 524-527.
Athyros, V. G., Doumas M., Imprialos K. P., Stavropoulos K., Georgianou E., Katsimardou A., et al. (2018).  Diabetes and lipid metabolism.. Hormones (Athens). 17(1), 61-67.
Papavramidou, N., & Christopoulou-Aletra H. (2007).  Diabetes and the 'Natural Faculties' in the Galenic treatises.. Hormones (Athens). 6(2), 157-9.
Paschou, S. A., Anagnostis P., Pavlou D. I., Vryonidou A., Goulis D. G., & Lambrinoudaki I. (2019).  Diabetes in Menopause: Risks and Management.. Curr Vasc Pharmacol. 17(6), 556-563.
Polyzos, S. A., & Mantzoros C. S. (2021).  Diabetes mellitus: 100 years since the discovery of insulin.. Metabolism. 118, 154737.
Hatzitolios, A. I., Didangelos T. P., Zantidis A. T., Tziomalos K., Giannakoulas G. A., & Karamitsos D. T. (2009).  Diabetes mellitus and cerebrovascular disease: which are the actual data?. J Diabetes Complications. 23(4), 283-96.
Anastasiadis, K., & Moschos G. (2007).  Diabetes mellitus and coronary revascularization procedures.. Int J Cardiol. 119(1), 10-4.
Moschopoulou, M., Ampatzidou F. Ch, Loutradis C., Boutou A., Koutsogiannidis C-P., Drosos G. E., et al. (2016).  Diabetes mellitus does not affect the incidence of acute kidney injury after cardiac surgery; a nested case-control study.. J Nephrol. 29(6), 835-845.
Loutradis, C., Skodra A., Georgianos P., Tolika P., Alexandrou D., Avdelidou A., et al. (2016).  Diabetes mellitus increases the prevalence of anemia in patients with chronic kidney disease: A nested case-control study.. World J Nephrol. 5(4), 358-66.
Ioannidis, I. (2014).  Diabetes treatment in patients with renal disease: Is the landscape clear enough?. World J Diabetes. 5(5), 651-8.
Sarafidis, P. A., & Lasaridis A. N. (2010).  Diabetic nephropathy: Endothelin antagonism for diabetic nephropathy.. Nat Rev Nephrol. 6(8), 447-9.
Baltzis, D., Roustit M., Grammatikopoulou M. G., Katsaboukas D., Athanasiou V., Iakovou I., et al. (2016).  Diabetic Peripheral Neuropathy as a Predictor of Asymptomatic Myocardial Ischemia in Type 2 Diabetes Mellitus: A Cross-Sectional Study.. Adv Ther. 33(10), 1840-1847.
Praidou, A., Androudi S., Brazitikos P., Karakiulakis G., Papakonstantinou E., Tsinopoulos I., et al. (2014).  Diabetic retinopathy treated with laser photocoagulation and the indirect effect on glycaemic control.. J Diabetes Res. 2014, 158251.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.